Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARADISE: CDED vs Corticosteroids in Active Crohn's Disease
NCT05284136Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2022
- Primary completion
- Aug 2025
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Endoscopic response at week 16. Planned start Apr 2022; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05284136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05284136.